痴呆中的冷漠:一项试点研究从神经精神病学和放射学角度提供了洞察力
1Department of Neurology, Hamidiye Faculty of Medicine, Sancaktepe Sehit Prof. Dr. Ilhan Varank SUAM, University of Health Sciences, Istanbul 34785, Turkey.
Journal of clinical medicine
|March 27, 2025
概括
漠不关心在痴呆症中很常见,影响阿尔茨海默病和其他类型. 这种症状与轨道前额区域的大脑变化有关,而不是认知衰退或情绪障碍.
科学领域:
- 神经科学是一个神经科学.
- 老年学是一门学科.
- 精神病学是一个精神病学.
背景情况:
- 漠不关心是所有痴呆症阶段普遍存在的一种神经心理症状,使患者的护理复杂化.
- 了解冷漠的流行率和相关因素对于管理痴呆症患者至关重要.
- 这项研究调查了阿尔茨海默氏症,莱维体痴呆症,前性痴呆症和血管痴呆症中的冷漠.
研究的目的:
- 为了确定不同痴呆症亚型中冷漠的流行率.
- 探索冷漠与认知功能,情绪症状和MRI发现之间的关联.
- 突出冷漠在痴呆症管理中的临床意义.
主要方法:
- 这是一项对200名痴呆症患者 (AD,LBD,FTD,VD) 和100名健康对照者的回顾性,横截面研究.
- 通过冷漠评价量表评估冷漠;通过GDS和GAS评估抑郁和焦虑.
- 通过MMSE和ACE-R测量认知功能;MRI分析轨道前额缩.
主要成果:
- 痴呆症和MCI患者的冷漠性明显比健康对照患者更常见.
- 在痴呆症亚型之间没有发现无动于衷的流行率的显著差异.
- 漠不关心与轨道前突缩缩有很强的相关性,但与抑郁症,焦虑症或认知得分无关.
结论:
- 漠不关心是与轨道前额缩相关的关键痴呆症症状,这给管理带来了挑战.
- 建议将冷漠度评估纳入常规临床实践.
- 需要进一步的纵向研究来阐明冷漠的病理生理学和痴呆症的治疗.
相关概念视频
Alzheimer's Disease: Overview
399
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
399
Dementia
78
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
78
Alzheimer's Disease: Treatment
137
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
137
Parkinson's Disease: Overview
399
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
399
Negative and Cognitive Symptoms of Schizophrenia
39
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
39
Neural Regulation
39.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.0K


